Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Chia‐Te Liao"'
Autor:
Huai Wen Liang, Wei Ru Chiou, Chien Yi Hsu, Wen Yu Lin, Ying Hsiang Lee, Chia Te Liao, Fa Po Chung, Jin Long Huang, Po Lin Lin, Hung Yu Chang
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 2, Pp 1204-1215 (2021)
ESC Heart Failure, Vol 8, Iss 2, Pp 1204-1215 (2021)
Aims Ivabradine and sacubitril/valsartan are second‐line therapies for patients with heart failure and reduced ejection fraction (HFrEF) based on guideline recommendations. We aimed to evaluate the synergistic effects of these two medications. Meth
Autor:
Wei Ting Chang, Chih Chen Chou, Mei Chuan Lee, Wen Shiann Wu, Carol Strong, Chia Te Liao, Tsung Yu, Han Siong Toh, Zhih Cherng Chen
Publikováno v:
Cardiovascular Drugs and Therapy. 35:539-547
This study aimed to investigate the cost-effectiveness of low-dose rivaroxaban plus aspirin versus aspirin alone for patients with stable cardiovascular diseases in the Taiwan setting. We constructed a Markov model to project the lifetime direct medi
Publikováno v:
AIDS. 34:903-911
OBJECTIVE The current study aims to assess the effect of early scale-up of antiretroviral therapy (ART) at HIV diagnosis on the economic burden of cardiometabolic diseases (CMDs) in HIV-infected population. DESIGN Cohort study. METHODS The study coho
Autor:
Han Siong Toh, Jung-Der Wang, Huang Tz Ou, Nai Ying Ko, Pin Hao Chen, Shihchen Kuo, Chun Ting Yang, Zhih Cherng Chen, Chia Te Liao
Publikováno v:
European Journal of Preventive Cardiology. 28:326-334
Aims There is a lack of studies that rigorously and systematically assess the economic burden of cardiovascular diseases (CVDs) related to the use of antiretroviral therapy (ART). We aimed to assess the association between adherence to ART and econom
Autor:
Chia Te Liao, Chien Yi Hsu, Po Lin Lin, Huai Wen Liang, Fa Po Chung, Hung Yu Chang, Ying Hsiang Lee, Wei Ru Chiou, Jin Long Huang, Wen Yu Lin
Publikováno v:
Journal of the Chinese Medical Association : JCMA. 84(6)
BACKGROUND Over recent years, new evolution in guideline-directed medical therapy (GDMT) contributes to clinical benefits in patients with heart failure and reduced ejection fraction (HFrEF). The additional medical expenditure may be a concern due to
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Although some studies have assessed the cost-effectiveness of percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI), there has been a lack of nationwide real-world studies estimating life expectancy (LE), loss-of-LE, life-year
Autor:
Mai Szu Wu, Yung Ho Hsu, Mei Yi Wu, Yen Chung Lin, Chia Te Liao, Cai Mei Zheng, Chih Cheng Hsu, Yuh Feng Lin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
Identifying modifiable risk factors of peritoneal dialysis (PD)-related peritonitis is of clinical importance in patient care. Mineral bone disease (MBD) has been associated with mortality and morbidity in end-stage kidney disease (ESKD) patients. Ho
Assessing the facilities and healthcare services for heart failure: Taiwan versus European countries
Autor:
Pei Lun Hung, Chun-Chieh Wang, Ying Chieh Liao, Hung Yu Chang, Kai Hsi Lu, Chien Yi Hsu, Chia Te Liao
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 1, Pp 258-268 (2022)
Background/Purpose The present study was designed to evaluate the local cardiology infrastructure and services for heart failure (HF) care in Taiwan hospitals and to compare the HF care with the hospitals in European countries. Methods Available data
Autor:
Chih Hsien Lin, Wei Ting Chang, Chon Seng Hong, Jhih Yuan Shih, Yen Wen Liu, Chia Te Liao, Zhih Cherng Chen
Publikováno v:
Journal of cardiology. 77(5)
Heart failure (HF) with mid-range ejection fraction (HFmrEF) is defined as HF with a left ventricular (LV) ejection fraction (LVEF) of 41-49%. However, the change in LV function and the subsequent prognosis in these patients remain unclear. We aimed
Autor:
Wen-Yu Lin, Chia-Te Liao, Hung Yu Chang, Po-Lin Lin, Ying-Hsiang Lee, Chien-Yi Hsu, Fa-Po Chung, Wei-Ru Chiou, Huai-Wen Liang
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy. 8(2)
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy (NICM) groups, the PARADIGM-HF study did not analyse the effect of ventr